About International Conference on Metabolomics

Cenetri Publishing Group looks forward to welcome all the participants across the Globe to attend "International Conference on Metabolomics" during February 26-28, 2018 at Bangkok, Thailand. The conference highlights the theme "Advancing Aspects in the Field of Metabolomics and Systems Biology". This Conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Metabolomics. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Metabolomics. We look forward to seeing you along with thousands of your colleagues from around the globe in Bangkok.

Scope and Importance:

The conference program covers a wide range of topics related to metabolomics while focusing on Health Problems. This metabolomics congress offers key insights into cutting-edge applications from global experts related to Metabolomics.
Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new omics - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.
'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.
Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery, pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.
The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Center for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Global Metabolomics Market by year wise



Why to attend ?

Meet Your Target Market with recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Metabolomics Related Associations around the Globe

  • Metabolomics Society
  • American association for the advancement of science
  • American association for clinical chemistry
  • American association for cancer research
  • American association of pharmaceutical scientists
  • Association for Consumer Research (ACR)
  • American cancer society
  • Bioinformatics society of India
  • Nutrigenomics Organization
  • The British Society for Genetic Medicine
  • The Genetics Society
  • Netherlands metabolomics center
  • The Australian biotechnology association
  • Human Proteome Organization
  • Indiana Proteomics Consortium
  • Proteome Society
  • European federation of biotechnology
  • Australasian Proteomics Society
  • Clinical Genetics Society

Target Audience

Directors/Managers & Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.
Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.

Glance at Market of Metabolomics

The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

Statistics which shows growth in importance of Metabolomics



This report segments the metabolomics market as follows:

Metabolomics Market: Technology Segment Analysis

  • High performance liquid chromatography
  • Mass spectrometry
  • Capillary electrophoresis
  • Gas chromatography
  • Nuclear magnetic resonance spectroscopy

Metabolomics Market: Indication Segment Analysis

  • Cardiology
  • Oncology

Metabolomics Market: Application Segment Analysis

  • Drug discovery
  • Biomarker
  • Nutrigenomics

Metabolomics Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Statistics of Industries Associated with Metabolomics

North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).


Fund Allotment towards Metabolomics Research

The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.

NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, USA.
  • Michigan Regional Comprehensive Metabolomics Resource Core (MRC2)
  • NIH West Coast Metabolomics Center at UC Davis
  • Southeast Center for Integrated Metabolomics (SECIM)
  • Metabolomics Core at Mayo Clinic
  • Research Center for Stable Isotope Resolved Metabolomics

Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.Metabolomic Diagnostics is engaged in a study called IMPROVED, which has received 6m Euros in European FP7 funding. Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics - the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.

Why Bangkok ?

Bangkok is the capital and most populous city of Thailand. Bangkok rapid growth amidst little urban planning and regulation has resulted in a haphazard cityscape and inadequate infrastructure systems. The city has since turned to public transport in an attempt to solve this major problem. Four rapid transit lines are now in operation, with more systems under construction or planned by the national government and the Bangkok Metropolitan Administration.

Bangkok welcomes more visitors than any other city in the world and it doesn't take long to realise why. Bangkok is a city of contrasts with action at every turn; marvel at the gleaming temples, catch a tuk tuk along the bustling Chinatown or take a long tail boat through floating markets. Food is another Bangkok highlight, from local dishes served at humble street stalls to haute cuisine at romantic rooftop restaurants.

Luxury malls compete with a sea of boutiques and markets, where you can treat yourself without overspending. Extravagant Luxury hotels and surprisingly cheap serviced apartments welcome you with the same famed Thai hospitality. And no visit to Bangkok would be complete without a glimpse of its famous nightlife - from cabarets to exotic red-light districts, Bangkok never ceases to amaze.

Bangkok Tourist Attractions

Bangkok is one of the world's top tourist destination cities. MasterCard ranked Bangkok as the top destination city by international visitor arrivals in its Global Destination Cities Index 2016, ahead of London with more than 21 million overnight visitors. Euro monitor International ranked Bangkok fourth in its Top City Destinations Ranking for 2016. Bangkok was also named "World's Best City" by Travel + Leisure magazine's survey of its readers for four consecutive years, from 2010 to 2013.

Among Bangkok's well-known sights are the Grand Palace and major Buddhist temples, including Wat Phra Kaew, Wat Pho, and Wat Arun. The Giant Swing and Erawan Shrine demonstrate Hinduism's deep-rooted influence in Thai culture. Vimanmek Mansion in Dusit Palace is famous as the world's largest teak building, while the Jim Thompson House provides an example of traditional Thai architecture. Other major museums include the Bangkok National Museum and the Royal Barge National Museum. Cruises and boat trips on the Chao Phraya and Thonburi's canals offer views of some of the city's traditional architecture and ways of life on the waterfront.

Shopping venues, many of which are popular with both tourists and locals range from the shopping centres and department stores concentrated in Siam and Ratchaprasong to the sprawling Chatuchak Weekend Market. Taling Chan Floating Market is among the few such markets in Bangkok. Yaowarat is known for its shops as well as street-side food stalls and restaurants, which are also found throughout the city. Khao San Road has long been famous as a backpacker's destination, with its budget accommodation, shops and bars attracting visitors from all over the world.

It is our pleasure to invite you to the International Conference on Metabolomics from 26-28th Feb, 2018 in Bangkok, Thailand. The conference has the theme of Building Advancing Aspects in the Field of Metabolomics and Systems Biology. The metabolomics market has witnessed substantial growth mostly due to the growing need for exact exploration of diseases, intensifying demand for personalized medicine, and development of innovative technologies. Nevertheless, need for well-qualified researchers, issues interrelated to data examination and processing, and the high cost of tools and mechanisms are detaining the growth of this market. ICOM 2018 intentions to bring together foremost academic scientists, researchers and research specialists to interchange and share their experiences and research results on all phases of Metabolomics. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Metabolomics. Conference topics can cover major directions in the field, such as Metabolomic Profiling, Metabolomic Database, Urine Metabolomics, Metabolic Syndrome, Therapeutic Metabolomics, Analytical Platforms in Metabolomics and Transcriptomics & Metabolic pathways. ICOM 2018 offers sessions including keynote lectures, poster presentations, workshops and informal exchange of opinions, scientific discussions between conference attendees. Conference offers friendly atmosphere and opportunity for the industry to sponsor exhibit their products.
We look forward to see you at the conference!


Habtom Ressom
Department of Oncology
Georgetown University Medical Center, USA

Ping Ching Hsu
Assistant Professor
University of Arkansas for Medical Sciences, USA

Robert Plumb
Director of Omics Sciences
Waters Corporation
USA

Graham Ewing
CEO
Mimex Montague Healthcare Ltd
UK

Pier Paolo Piccaluga
Department of Experimental, Diagnostic and Specialty Medicine
University of Bologna, Italy

Md. Altaf-Ul-Amin
Dept. of Information Science
Nara Institute of Science & Technology, Japan

Ljubica Tasic
Dept. of Organic Chemistry
University of Campinas
Brazil

Afaf Elansary
Professor
King Saud University
Saudi Arabia

Medhat Mohamed El-Moselhy
Associate Professor
University of Jazan
Saudi Arabia

Kenneth K Wu
Distinguished Chair Professor
National Taiwan University College of Medicine, Taiwan

Baharudin Ibrahim
Dept of Clinical Pharmacy
Universiti Sains Malaysia
Malaysia

P. K. Ragunath
Head, Department of Bioinformatics
Sri Ramachandra University
India

Jaleel Kareem Ahmed
Professor of physical chemistry
University of Babylon
Iraq

Metabolomics is principally the logical study of the metabolites. In detail, metabolomics is a study of distinctive chemical thumbprints that are left behind by specific cellular processes, the study of their metabolites profiles of small molecules. Metabolome is a pool of all the metabolites in a biological cell, tissue, or body, which are the final products of cellular processes. mRNA expression data of genes and proteomic analyses reveal all the gene products are produced in the cell, data representing an aspect of cellular function. Conversely, metabolic profiling can give an overview of the physiology of the cell. One of the challenges of functional genomics and systems biology is to integrate proteomics information, transcriptomics and metabolomics to provide a better understanding of cell biology.

Technical Sessions
Metabolomic Profiling
Metabolomic Database
Metabolomic Analysis
Human Metabolomics
Single Cell Metabolomics
Mass Spectrometry Based Metabolomics
Urine Metabolomics
Clinical Metabolomics & Lipidomics
Cancer Therapeutic Approaches
Plant & Environmental Metabolomics
Metabolic Syndrome
Metabolomics in Precision Medicine
Food & Nutritional Metabolomics
Frontiers of Metabolomics Research
Metabolomic Devices
Therapeutic Metabolomics
Analytical Platforms in Metabolomics
Transcriptomics & Metabolic Pathways
Metabolic Modelling
Metabolism in Obesity Patients
Advancements in Metabolomics Research
Metabolism in Diabetic Patients
Primary & Secondary Metabolites
Cancer Metabolism
Iron & Carbohydrate Metabolism
Bioinformatics Tools in Metabolic Pathways
This browser does not support PDFs. Please download the PDF to view it: Download PDF.